These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 36206805)
1. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Talwar A; Estes E; Aparasu R; Reddy DS Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805 [TBL] [Abstract][Full Text] [Related]
2. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials. Gunning B; Mazurkiewicz-Bełdzińska M; Chin RFM; Bhathal H; Nortvedt C; Dunayevich E; Checketts D Acta Neurol Scand; 2021 Feb; 143(2):154-163. PubMed ID: 32969022 [TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A; Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635 [TBL] [Abstract][Full Text] [Related]
4. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312 [TBL] [Abstract][Full Text] [Related]
5. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome. Nabbout R; Arzimanoglou A; Auvin S; Berquin P; Desurkar A; Fuller D; Nortvedt C; Pulitano P; Rosati A; Soto V; Villanueva V; Cross JH Seizure; 2023 Aug; 110():78-85. PubMed ID: 37331197 [TBL] [Abstract][Full Text] [Related]
6. Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Silvinato A; Floriano I; Bernardo WM Rev Assoc Med Bras (1992); 2022; 68(10):1345-1357. PubMed ID: 36417631 [TBL] [Abstract][Full Text] [Related]
7. Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials. Devinsky O; Thiele EA; Wright S; Checketts D; Morrison G; Dunayevich E; Knappertz V Acta Neurol Scand; 2020 Dec; 142(6):531-540. PubMed ID: 32592183 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis. Lattanzi S; Brigo F; Trinka E; Zaccara G; Cagnetti C; Del Giovane C; Silvestrini M Drugs; 2018 Nov; 78(17):1791-1804. PubMed ID: 30390221 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies. Reddy DS Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806 [TBL] [Abstract][Full Text] [Related]
10. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials. Bialer M; Perucca E Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568 [TBL] [Abstract][Full Text] [Related]
11. Anti-seizure medications for Lennox-Gastaut syndrome. Brigo F; Jones K; Eltze C; Matricardi S Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230 [TBL] [Abstract][Full Text] [Related]
12. Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy. Georgieva D; Langley J; Hartkopf K; Hawk L; Margolis A; Struck A; Felton E; Hsu D; Gidal BE Epilepsy Behav; 2023 Apr; 141():109159. PubMed ID: 36893722 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain. García-Peñas JJ; Gil Nagel-Rein A; Sánchez-Carpintero R; Villanueva-Haba V Rev Neurol; 2021 Sep; 73(S01):S1-S8. PubMed ID: 34486101 [TBL] [Abstract][Full Text] [Related]
14. Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Wechsler RT; Burdette DE; Gidal BE; Hyslop A; McGoldrick PE; Thiele EA; Valeriano J Epilepsia Open; 2024 Oct; 9(5):1632-1642. PubMed ID: 39007525 [TBL] [Abstract][Full Text] [Related]
15. Cannabis for the Treatment of Epilepsy: an Update. Gaston TE; Szaflarski JP Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis. Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848 [TBL] [Abstract][Full Text] [Related]
17. Real-world evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex. Espinosa-Jovel C; Riveros S; Bolaños-Almeida C; Salazar MR; Inga LC; Guío L Seizure; 2023 Nov; 112():72-76. PubMed ID: 37769547 [TBL] [Abstract][Full Text] [Related]
18. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511 [TBL] [Abstract][Full Text] [Related]
19. Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis. Devi N; Madaan P; Ameen R; Sahu JK; Bansal D Seizure; 2022 Jul; 99():164-175. PubMed ID: 35487871 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. Franco V; Perucca E Drugs; 2019 Sep; 79(13):1435-1454. PubMed ID: 31372958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]